Bridgebio Pharma Inc (BBIO) vs peers

$68.56

Latest weekly close · Market cap $13.4B

BBIO's P/E is not meaningful or is unavailable. Choose another measure to compare peers.

Peer group: Biotechnology. Updated Oct 24, 2026.

BBIO and Biotechnology, ranked by P/E
Stock	P/E	Own 5-year percentile
BBIOBridgebio Pharma Inc	n/a	n/a, not ranked
ABBVAbbVieUpdated Oct 23, 2026	80.6×	76
BIIBBiogenUpdated Oct 23, 2026	44.8×	100
VRTXVertex PharmaceuticalsUpdated Oct 23, 2026	30.6×	80
AMGNAmgenUpdated Oct 23, 2026	27.4×	78
REGNRegeneron PharmaceuticalsUpdated Oct 23, 2026	19.9×	67
INCYIncyteUpdated Oct 23, 2026	14.7×	5
GILDGilead SciencesUpdated Oct 23, 2026	n/a	n/a, not ranked
MRNAModernaUpdated Oct 23, 2026	n/a	n/a, not ranked
Peer median	29.0×

How to read this comparison

Up to eight covered companies in the same industry, largest market value first.

P/E divides the share price by earnings per share over the last twelve months. The peer median leaves out BBIO and stocks without a reading.

Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its P/E is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.

Different growth rates, margins and financial risks can explain different multiples. Stocks without positive earnings have no reading.

BBIO versus the peer median

n/a

BBIO: n/a
Peer median: 29.0×
Own 5-year median: n/a

BBIO P/E history Calculate BBIO's implied price